Multiple randomized clinical trials and electronic health record studies now show that metformin, a widely used and well-established medication, significantly reduces the risk of developing long COVID ...

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...

Several illnesses - including COVID-19 - are currently circulating statewide.

Another deadly virus is threatening the world, bringing back memories of the coronavirus and how ill-prepared the health systems of many countries, including the Philippines, were in dealing with it ...

Long COVID affects people differently from varied geographical locations. Patients in the U.S. reported much more brain fog symptoms than those in India or Nigeria.

Eyam Health and iiDiagnostics (iiDX), a company formed by the Infection Innovation Consortium: iiCON, have launched a ...

Two little-known animal viruses, influenza D and canine coronavirus, show signs of adapting to humans, according to experts.

By Hugo Francisco de Souza A new perspective highlights how the influenza D virus and a canine–feline recombinant coronavirus ...

A DW investigation traces the hidden financial web behind deep-sea mining — an industry scientists say remains poorly understood, yet capable of causing irreversible harm to oceans worldwide.

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm: SYNACT), a clinical-stage biotechnological company focused on treating inflammation through resolution therapy, today announced that it has initia ...

Results highlight the possibility of using a blood test to identify people at increased risk of chronic lung disease ...